Meloxicam v bedinvetmab (Librela). Real world data and insights from a UK comparative field study
15 Nov 2024
Platinum Suite - Level 3
This study will report the FIRST comparitor clinical trial of bedinvetmab v meloxicam for the alleviation of pain associated with canine osteoarthritis. This was a multi-centre, open label, randomised clinical trial in over 100 dogs. Efficacy was measured with the Canine Orthopedic Index and adverse events were recorded. Per protocol and intent-to-treat analyses were performed for efficacy and safety. Come along to hear the results!
Learning Outcomes
' Understand the measurement of outcomes in osteoarthritis
' Understand study design
' Learn about safety and efficacy of bedinvetmab (Librela) and meloxicam
)
)
)
){kind=logo}
)
){kind=icon}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)
){kind=logo}
)
)
){kind=logo}
)
)
)
){kind=logo}
)
)
){kind=logo}